NCT00980681View on ClinicalTrials.gov

Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)

PHASE3TerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Renal Disease

Interventions

DRUG

Dotarem

Each subject will receive one injection of Dotarem 0.2ml/kg

OTHER

Time of Flight

Each subject will undergo a TOF MRA

Trial Locations (1)

47403

Guerbet LLC, Bloomington

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Guerbet

INDUSTRY